| Literature DB >> 24552706 |
Seungrie Han1, Soontaek Hong, Jiwon Mo, Dongmin Lee, Eunju Choi, June-seek Choi, Woong Sun, Hyun Woo Lee, Hyun Kim.
Abstract
Inductive expression of early growth response 1 (Egr-1) in neurons is associated with many forms of neuronal activity. However, only a few Egr-1 target genes are known in the brain. The results of this study demonstrate that Egr-1 knockout (KO) mice display impaired contextual extinction learning and normal fear acquisition relative to wild-type (WT) control animals. Genome-wide microarray experiments revealed 368 differentially expressed genes in the hippocampus of Egr-1 WT exposed to different phases of a fear conditioning paradigm compared to gene expression profiles in the hippocampus of KO mice. Some of genes, such as serotonin receptor 2C (Htr2c), neuropeptide B (Npb), neuronal PAS domain protein 4 (Npas4), NPY receptor Y1 (Npy1r), fatty acid binding protein 7 (Fabp7), and neuropeptide Y (Npy) are known to regulate processing of fearful memories, and promoter analyses demonstrated that several of these genes contained Egr-1 binding sites. This study provides a useful list of potential Egr-1 target genes which may be regulated during fear memory processing.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24552706 PMCID: PMC3907009 DOI: 10.14348/molcells.2014.2206
Source DB: PubMed Journal: Mol Cells ISSN: 1016-8478 Impact factor: 5.034
Fig. 2.Microarray experiments and analyses. (A) Schematic diagram illustrating the CFC procedures. ❶, ❷, ❸, ❹, and ❺ indicate five different groups: ❶, naïve control (no treatment); ❷, 30 min after CFC; ❸, 1 day after conditioning; ❹, 30 min after the retrieval test; and ❺, 2 h after the retrieval test. All mice (two WT and two KO mice per group) were sacrificed at the indicated time points. (B) Gene expression microarrays were performed on hippocampi dissected from Egr-1 KO and WT mice. Venn diagrams show the differentially expressed genes (DEGs) with a fold change of 1.3 greater based on pairwise comparisons of each experimental group relative to naïve groups in Egr-1WT (a + a″, b + b″, and c + c″) and KO (a′ + a″, b′ + b″, and c′ + c″) mice. The genes labeled a, b, and c were DEGs specific to WT mice. (C) Summary of the microarray results. Circles represent the WT-specific DEGs in each group. These groups were: 30 min after fear conditioning (orange circle), 30 min after the retrieval test (emerald circle), and 2 h after the retrieval test (purple circle). The numbers in parentheses inside each compartment indicate the number of DEGs. The intersections of the sets indicate DEGs that were found in multiple groups.
Fig. 1.Contextual fear conditioning (CFC) of Egr-1 KO mice. (A) Time line of CFC procedure. (B) Association between conditioned stimulus (CS, context) and unconditioned stimulus (US, foot shocks). (C) Freezing behaviors of indicated genotypes during conditioning and retrieval sessions. All mice subjected to CFC displayed robust freezing behavior. (D) Freezing behaviors of mice during extinction trials (4 day) and during spontaneous recovery of CFC (7 days after the last extinction trial). Bars ± error bars in the histogram represent mean ± SEM (n = 5 for wild type; n = 3 for KO mice). Asterisks represent level of significance (*P < 0.05; **P < 0.01) indicated by post hoc ANOVA Fisher’s LSD test. CFC, contextual fear conditioning; EXT1-4, contextual fear extinction day1-4; and SR, spontaneous recovery.
Promoter analysis for Egr-1 binding site
| Group | DEG | Full name | # of Egr-1 binding sites |
|---|---|---|---|
| 1 | Rho guanine nucleotide exchange factor 5 | 1 | |
| Chemokine (C-C motif) ligand 3 | |||
| Estrogen receptor 1 (alpha) | 1 | ||
| Gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 | |||
| 5-Hydroxytryptamine (serotonin) receptor 2C | 1 | ||
| Interleukin 2 | |||
| Interleukin 5 | |||
| Interleukin 15 | |||
| Interleukin 16 | |||
| Interleukin 25 | 2 | ||
| Insulin II | |||
| Melanocortin 3 receptor | |||
| Neuropeptide B | 1 | ||
| Protein inhibitor of activated STAT1 | 4 | ||
| RAS protein-specific guanine nucleotide-releasing factor 2 | 1 | ||
| SH3/ankyrin domain gene 2 | 3 | ||
| 2 | Rho GTPase activaing protein 6 | ||
| Neuronal PAS domain protein 4 | 10 | ||
| Neuropeptide Y receptor Y1 | 1 | ||
| Secretagogin, EF-hand calcium binding protein | |||
| 3 | v-Erb-b2 erythroblastic leukemia viral oncogene homolog 3 | 3 | |
| Fatty acid binding protein 7, brain | 2 | ||
| 5 | Unc-13 homolog C (C. elegans) | ||
| 6 | Interleukin 2 receptor, gamma chain | 2 | |
| 7 | Cerebellin 1 precursor protein | 9 | |
| Growth hormone | 7 | ||
| Neuropeptide Y | 2 | ||
| Phosphodiesterase 11A | 3 | ||
| Protein kinase C, delta | 2 |
Group, indicate each compartment in Fig. 2C; DEG, differentially expressed gene
Fig. 3.Gene ontology (GO) annotation of WT-specific DEGs. Each pie chart represents the distribution of the GO annotations into functional categories for biological process (A) and molecular functions (B). The values in parentheses indicate the percentage of functional annotations.